Ryman Healthcare Ltd Stock Performance
| RYHTY Stock | USD 8.01 0.60 6.97% |
The company holds a Beta of 0.48, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Ryman Healthcare's returns are expected to increase less than the market. However, during the bear market, the loss of holding Ryman Healthcare is expected to be smaller as well. Ryman Healthcare right now holds a risk of 1.45%. Please check Ryman Healthcare skewness, as well as the relationship between the day median price and period momentum indicator , to decide if Ryman Healthcare will be following its historical price patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Ryman Healthcare Ltd has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Ryman Healthcare is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 20.2 M | |
| Total Cashflows From Investing Activities | -787.3 M |
Ryman |
Ryman Healthcare Relative Risk vs. Return Landscape
If you would invest 800.00 in Ryman Healthcare Ltd on November 10, 2025 and sell it today you would earn a total of 1.00 from holding Ryman Healthcare Ltd or generate 0.13% return on investment over 90 days. Ryman Healthcare Ltd is currently producing 0.0125% returns and takes up 1.452% volatility of returns over 90 trading days. Put another way, 13% of traded pink sheets are less volatile than Ryman, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Ryman Healthcare Target Price Odds to finish over Current Price
The tendency of Ryman Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 8.01 | 90 days | 8.01 | about 78.57 |
Based on a normal probability distribution, the odds of Ryman Healthcare to move above the current price in 90 days from now is about 78.57 (This Ryman Healthcare Ltd probability density function shows the probability of Ryman Pink Sheet to fall within a particular range of prices over 90 days) .
Ryman Healthcare Price Density |
| Price |
Predictive Modules for Ryman Healthcare
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ryman Healthcare. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ryman Healthcare's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Ryman Healthcare Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Ryman Healthcare is not an exception. The market had few large corrections towards the Ryman Healthcare's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Ryman Healthcare Ltd, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Ryman Healthcare within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.04 | |
β | Beta against Dow Jones | 0.48 | |
σ | Overall volatility | 0.24 | |
Ir | Information ratio | -0.05 |
Ryman Healthcare Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Ryman Healthcare for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Ryman Healthcare can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Ryman Healthcare Ltd has accumulated 2.58 B in total debt with debt to equity ratio (D/E) of 0.76, which is about average as compared to similar companies. Ryman Healthcare has a current ratio of 0.7, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Ryman Healthcare until it has trouble settling it off, either with new capital or with free cash flow. So, Ryman Healthcare's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Ryman Healthcare sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Ryman to invest in growth at high rates of return. When we think about Ryman Healthcare's use of debt, we should always consider it together with cash and equity. |
Ryman Healthcare Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Ryman Pink Sheet often depends not only on the future outlook of the current and potential Ryman Healthcare's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ryman Healthcare's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 100 M | |
| Cash And Short Term Investments | 28.3 M |
Ryman Healthcare Fundamentals Growth
Ryman Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Ryman Healthcare, and Ryman Healthcare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Ryman Pink Sheet performance.
| Return On Equity | 0.18 | |||
| Return On Asset | -7.0E-4 | |||
| Profit Margin | 1.13 % | |||
| Operating Margin | (0.02) % | |||
| Current Valuation | 3.91 B | |||
| Shares Outstanding | 100 M | |||
| Price To Earning | 10.13 X | |||
| Price To Book | 0.85 X | |||
| Price To Sales | 3.74 X | |||
| Revenue | 503.76 M | |||
| EBITDA | 788.44 M | |||
| Cash And Equivalents | 47.88 M | |||
| Cash Per Share | 0.48 X | |||
| Total Debt | 2.58 B | |||
| Debt To Equity | 0.76 % | |||
| Book Value Per Share | 36.28 X | |||
| Cash Flow From Operations | 585.98 M | |||
| Earnings Per Share | 3.82 X | |||
| Total Asset | 10.97 B | |||
| Retained Earnings | 1.28 B | |||
| Current Asset | 221 M | |||
| Current Liabilities | 107 M | |||
About Ryman Healthcare Performance
Evaluating Ryman Healthcare's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Ryman Healthcare has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Ryman Healthcare has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the elderly in New Zealand and Australia. The company was founded in 1984 and is based in Christchurch, New Zealand. Ryman Healthcare operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange. It employs 6700 people.Things to note about Ryman Healthcare performance evaluation
Checking the ongoing alerts about Ryman Healthcare for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Ryman Healthcare help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Ryman Healthcare Ltd has accumulated 2.58 B in total debt with debt to equity ratio (D/E) of 0.76, which is about average as compared to similar companies. Ryman Healthcare has a current ratio of 0.7, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Ryman Healthcare until it has trouble settling it off, either with new capital or with free cash flow. So, Ryman Healthcare's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Ryman Healthcare sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Ryman to invest in growth at high rates of return. When we think about Ryman Healthcare's use of debt, we should always consider it together with cash and equity. |
- Analyzing Ryman Healthcare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Ryman Healthcare's stock is overvalued or undervalued compared to its peers.
- Examining Ryman Healthcare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Ryman Healthcare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Ryman Healthcare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Ryman Healthcare's pink sheet. These opinions can provide insight into Ryman Healthcare's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Ryman Pink Sheet Analysis
When running Ryman Healthcare's price analysis, check to measure Ryman Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ryman Healthcare is operating at the current time. Most of Ryman Healthcare's value examination focuses on studying past and present price action to predict the probability of Ryman Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ryman Healthcare's price. Additionally, you may evaluate how the addition of Ryman Healthcare to your portfolios can decrease your overall portfolio volatility.